nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—FADS1—stomach cancer	0.567	0.753	CbGaD
Icosapent—PPARG—stomach cancer	0.13	0.173	CbGaD
Icosapent—PTGS2—stomach cancer	0.0551	0.0732	CbGaD
Icosapent—TRPV1—vagus nerve—stomach cancer	0.013	0.144	CbGeAlD
Icosapent—FFAR1—pancreas—stomach cancer	0.00785	0.087	CbGeAlD
Icosapent—Alpha-Linolenic Acid—FADS1—stomach cancer	0.00386	0.888	CrCbGaD
Icosapent—SLC8A1—hematopoietic system—stomach cancer	0.00318	0.0352	CbGeAlD
Icosapent—ACSL3—pancreas—stomach cancer	0.00312	0.0346	CbGeAlD
Icosapent—SLC8A1—smooth muscle tissue—stomach cancer	0.0028	0.031	CbGeAlD
Icosapent—PPARG—Topotecan—Irinotecan—stomach cancer	0.0028	1	CbGdCrCtD
Icosapent—ACSL3—digestive system—stomach cancer	0.00267	0.0296	CbGeAlD
Icosapent—SLC8A1—digestive system—stomach cancer	0.00221	0.0245	CbGeAlD
Icosapent—ACSL3—endocrine gland—stomach cancer	0.0022	0.0244	CbGeAlD
Icosapent—ACSL3—liver—stomach cancer	0.00199	0.022	CbGeAlD
Icosapent—TRPV1—epithelium—stomach cancer	0.00194	0.0215	CbGeAlD
Icosapent—ACSL4—hematopoietic system—stomach cancer	0.00193	0.0213	CbGeAlD
Icosapent—FADS1—smooth muscle tissue—stomach cancer	0.00187	0.0207	CbGeAlD
Icosapent—PPARD—hematopoietic system—stomach cancer	0.00185	0.0205	CbGeAlD
Icosapent—SLC8A1—endocrine gland—stomach cancer	0.00183	0.0202	CbGeAlD
Icosapent—FADS1—pancreas—stomach cancer	0.00173	0.0191	CbGeAlD
Icosapent—TRPV1—pancreas—stomach cancer	0.00173	0.0191	CbGeAlD
Icosapent—PPARG—blood vessel—stomach cancer	0.00163	0.018	CbGeAlD
Icosapent—FABP7—digestive system—stomach cancer	0.00163	0.018	CbGeAlD
Icosapent—ACSL4—pancreas—stomach cancer	0.00157	0.0174	CbGeAlD
Icosapent—PPARD—pancreas—stomach cancer	0.00151	0.0167	CbGeAlD
Icosapent—TRPV1—digestive system—stomach cancer	0.00147	0.0163	CbGeAlD
Icosapent—FADS1—bone marrow—stomach cancer	0.00136	0.0151	CbGeAlD
Icosapent—FABP7—endocrine gland—stomach cancer	0.00134	0.0149	CbGeAlD
Icosapent—ACSL4—digestive system—stomach cancer	0.00134	0.0148	CbGeAlD
Icosapent—PPARD—lymphoid tissue—stomach cancer	0.0013	0.0144	CbGeAlD
Icosapent—PPARD—digestive system—stomach cancer	0.00129	0.0142	CbGeAlD
Icosapent—ACSL4—bone marrow—stomach cancer	0.00123	0.0137	CbGeAlD
Icosapent—TRPV1—endocrine gland—stomach cancer	0.00122	0.0135	CbGeAlD
Icosapent—ACSL4—endocrine gland—stomach cancer	0.00111	0.0123	CbGeAlD
Icosapent—FADS1—liver—stomach cancer	0.0011	0.0122	CbGeAlD
Icosapent—PPARD—endocrine gland—stomach cancer	0.00106	0.0118	CbGeAlD
Icosapent—ACSL4—liver—stomach cancer	0.000998	0.0111	CbGeAlD
Icosapent—PPARD—liver—stomach cancer	0.000958	0.0106	CbGeAlD
Icosapent—PTGS1—blood vessel—stomach cancer	0.00087	0.00964	CbGeAlD
Icosapent—PPARG—hematopoietic system—stomach cancer	0.000866	0.0096	CbGeAlD
Icosapent—FADS1—lymph node—stomach cancer	0.000842	0.00934	CbGeAlD
Icosapent—PTGS2—blood vessel—stomach cancer	0.000831	0.00921	CbGeAlD
Icosapent—PPARG—epithelium—stomach cancer	0.000792	0.00878	CbGeAlD
Icosapent—PTGS2—gall bladder—stomach cancer	0.000782	0.00867	CbGeAlD
Icosapent—ACSL4—lymph node—stomach cancer	0.000765	0.00848	CbGeAlD
Icosapent—PPARG—smooth muscle tissue—stomach cancer	0.000763	0.00846	CbGeAlD
Icosapent—PPARD—lymph node—stomach cancer	0.000734	0.00814	CbGeAlD
Icosapent—PPARG—pancreas—stomach cancer	0.000705	0.00782	CbGeAlD
Icosapent—PPARG—lymphoid tissue—stomach cancer	0.00061	0.00676	CbGeAlD
Icosapent—PPARG—digestive system—stomach cancer	0.000603	0.00668	CbGeAlD
Icosapent—PPARG—bone marrow—stomach cancer	0.000555	0.00616	CbGeAlD
Icosapent—PPARG—endocrine gland—stomach cancer	0.000498	0.00552	CbGeAlD
Icosapent—Dihomo-gamma-linolenic acid—PTGS2—stomach cancer	0.00049	0.112	CrCbGaD
Icosapent—PTGS1—hematopoietic system—stomach cancer	0.000463	0.00513	CbGeAlD
Icosapent—PPARG—liver—stomach cancer	0.000449	0.00497	CbGeAlD
Icosapent—PTGS2—hematopoietic system—stomach cancer	0.000443	0.00491	CbGeAlD
Icosapent—PTGS1—epithelium—stomach cancer	0.000423	0.00469	CbGeAlD
Icosapent—PTGS1—smooth muscle tissue—stomach cancer	0.000408	0.00452	CbGeAlD
Icosapent—PTGS2—epithelium—stomach cancer	0.000405	0.00448	CbGeAlD
Icosapent—PTGS2—smooth muscle tissue—stomach cancer	0.00039	0.00432	CbGeAlD
Icosapent—PTGS2—pancreas—stomach cancer	0.00036	0.004	CbGeAlD
Icosapent—PPARG—lymph node—stomach cancer	0.000344	0.00381	CbGeAlD
Icosapent—PTGS1—digestive system—stomach cancer	0.000322	0.00357	CbGeAlD
Icosapent—PTGS2—lymphoid tissue—stomach cancer	0.000312	0.00345	CbGeAlD
Icosapent—PTGS2—digestive system—stomach cancer	0.000308	0.00341	CbGeAlD
Icosapent—PTGS2—bone marrow—stomach cancer	0.000284	0.00315	CbGeAlD
Icosapent—Anaphylactic shock—Floxuridine—stomach cancer	0.000283	0.0425	CcSEcCtD
Icosapent—PTGS1—endocrine gland—stomach cancer	0.000266	0.00295	CbGeAlD
Icosapent—PTGS2—endocrine gland—stomach cancer	0.000254	0.00282	CbGeAlD
Icosapent—PTGS2—liver—stomach cancer	0.000229	0.00254	CbGeAlD
Icosapent—Oropharyngeal pain—Docetaxel—stomach cancer	0.000206	0.0308	CcSEcCtD
Icosapent—Oropharyngeal pain—Capecitabine—stomach cancer	0.000199	0.0298	CcSEcCtD
Icosapent—PTGS1—lymph node—stomach cancer	0.000184	0.00204	CbGeAlD
Icosapent—Vomiting—Floxuridine—stomach cancer	0.00018	0.027	CcSEcCtD
Icosapent—Rash—Floxuridine—stomach cancer	0.000179	0.0268	CcSEcCtD
Icosapent—Dermatitis—Floxuridine—stomach cancer	0.000179	0.0267	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Irinotecan—stomach cancer	0.000177	0.0265	CcSEcCtD
Icosapent—PTGS2—lymph node—stomach cancer	0.000176	0.00195	CbGeAlD
Icosapent—Vomiting—Mitomycin—stomach cancer	0.000141	0.0212	CcSEcCtD
Icosapent—Rash—Mitomycin—stomach cancer	0.00014	0.021	CcSEcCtD
Icosapent—Dermatitis—Mitomycin—stomach cancer	0.00014	0.021	CcSEcCtD
Icosapent—Eructation—Epirubicin—stomach cancer	0.000124	0.0186	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Docetaxel—stomach cancer	0.000122	0.0183	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.00012	0.0179	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.000118	0.0177	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.000116	0.0174	CcSEcCtD
Icosapent—Eructation—Doxorubicin—stomach cancer	0.000115	0.0172	CcSEcCtD
Icosapent—Anaphylactic shock—Irinotecan—stomach cancer	9.66e-05	0.0145	CcSEcCtD
Icosapent—Anaphylactic shock—Fluorouracil—stomach cancer	9.25e-05	0.0139	CcSEcCtD
Icosapent—Dyspepsia—Irinotecan—stomach cancer	8.5e-05	0.0127	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Fluorouracil—stomach cancer	8.43e-05	0.0126	CcSEcCtD
Icosapent—Gastrointestinal disorder—Irinotecan—stomach cancer	8.34e-05	0.0125	CcSEcCtD
Icosapent—Constipation—Irinotecan—stomach cancer	8.26e-05	0.0124	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Epirubicin—stomach cancer	8.25e-05	0.0124	CcSEcCtD
Icosapent—Malnutrition—Docetaxel—stomach cancer	8.18e-05	0.0123	CcSEcCtD
Icosapent—Dyspepsia—Fluorouracil—stomach cancer	8.14e-05	0.0122	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Epirubicin—stomach cancer	8.08e-05	0.0121	CcSEcCtD
Icosapent—Dysgeusia—Docetaxel—stomach cancer	8.01e-05	0.012	CcSEcCtD
Icosapent—Gastrointestinal disorder—Fluorouracil—stomach cancer	7.99e-05	0.012	CcSEcCtD
Icosapent—Malnutrition—Capecitabine—stomach cancer	7.92e-05	0.0119	CcSEcCtD
Icosapent—Dysgeusia—Capecitabine—stomach cancer	7.76e-05	0.0116	CcSEcCtD
Icosapent—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	7.63e-05	0.0114	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Doxorubicin—stomach cancer	7.48e-05	0.0112	CcSEcCtD
Icosapent—Arthralgia—Docetaxel—stomach cancer	6.96e-05	0.0104	CcSEcCtD
Icosapent—Arthralgia—Capecitabine—stomach cancer	6.74e-05	0.0101	CcSEcCtD
Icosapent—Anaphylactic shock—Docetaxel—stomach cancer	6.68e-05	0.01	CcSEcCtD
Icosapent—Pruritus—Fluorouracil—stomach cancer	6.54e-05	0.0098	CcSEcCtD
Icosapent—Vomiting—Irinotecan—stomach cancer	6.14e-05	0.0092	CcSEcCtD
Icosapent—Rash—Irinotecan—stomach cancer	6.09e-05	0.00912	CcSEcCtD
Icosapent—Dermatitis—Irinotecan—stomach cancer	6.08e-05	0.00911	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Docetaxel—stomach cancer	6.08e-05	0.00911	CcSEcCtD
Icosapent—Malnutrition—Methotrexate—stomach cancer	5.9e-05	0.00883	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Capecitabine—stomach cancer	5.89e-05	0.00882	CcSEcCtD
Icosapent—Vomiting—Fluorouracil—stomach cancer	5.88e-05	0.00881	CcSEcCtD
Icosapent—Dyspepsia—Docetaxel—stomach cancer	5.88e-05	0.0088	CcSEcCtD
Icosapent—Rash—Fluorouracil—stomach cancer	5.83e-05	0.00874	CcSEcCtD
Icosapent—Dermatitis—Fluorouracil—stomach cancer	5.83e-05	0.00873	CcSEcCtD
Icosapent—Dysgeusia—Methotrexate—stomach cancer	5.77e-05	0.00865	CcSEcCtD
Icosapent—Gastrointestinal disorder—Docetaxel—stomach cancer	5.76e-05	0.00863	CcSEcCtD
Icosapent—Constipation—Docetaxel—stomach cancer	5.71e-05	0.00855	CcSEcCtD
Icosapent—Dyspepsia—Capecitabine—stomach cancer	5.69e-05	0.00852	CcSEcCtD
Icosapent—Gastrointestinal disorder—Capecitabine—stomach cancer	5.58e-05	0.00836	CcSEcCtD
Icosapent—Constipation—Capecitabine—stomach cancer	5.53e-05	0.00828	CcSEcCtD
Icosapent—Malnutrition—Epirubicin—stomach cancer	5.52e-05	0.00827	CcSEcCtD
Icosapent—Dysgeusia—Epirubicin—stomach cancer	5.4e-05	0.00809	CcSEcCtD
Icosapent—Malnutrition—Doxorubicin—stomach cancer	5.1e-05	0.00765	CcSEcCtD
Icosapent—Arthralgia—Methotrexate—stomach cancer	5.02e-05	0.00752	CcSEcCtD
Icosapent—Dysgeusia—Doxorubicin—stomach cancer	5e-05	0.00749	CcSEcCtD
Icosapent—Anaphylactic shock—Methotrexate—stomach cancer	4.81e-05	0.00721	CcSEcCtD
Icosapent—Pruritus—Docetaxel—stomach cancer	4.72e-05	0.00708	CcSEcCtD
Icosapent—Arthralgia—Epirubicin—stomach cancer	4.7e-05	0.00704	CcSEcCtD
Icosapent—Pruritus—Capecitabine—stomach cancer	4.57e-05	0.00685	CcSEcCtD
Icosapent—Anaphylactic shock—Epirubicin—stomach cancer	4.5e-05	0.00675	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.38e-05	0.00657	CcSEcCtD
Icosapent—Arthralgia—Doxorubicin—stomach cancer	4.35e-05	0.00651	CcSEcCtD
Icosapent—Vomiting—Docetaxel—stomach cancer	4.24e-05	0.00636	CcSEcCtD
Icosapent—Dyspepsia—Methotrexate—stomach cancer	4.24e-05	0.00635	CcSEcCtD
Icosapent—Rash—Docetaxel—stomach cancer	4.21e-05	0.00631	CcSEcCtD
Icosapent—Dermatitis—Docetaxel—stomach cancer	4.21e-05	0.0063	CcSEcCtD
Icosapent—Anaphylactic shock—Doxorubicin—stomach cancer	4.17e-05	0.00624	CcSEcCtD
Icosapent—Gastrointestinal disorder—Methotrexate—stomach cancer	4.15e-05	0.00622	CcSEcCtD
Icosapent—Vomiting—Capecitabine—stomach cancer	4.11e-05	0.00616	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.1e-05	0.00615	CcSEcCtD
Icosapent—Rash—Capecitabine—stomach cancer	4.08e-05	0.00611	CcSEcCtD
Icosapent—Dermatitis—Capecitabine—stomach cancer	4.07e-05	0.0061	CcSEcCtD
Icosapent—Dyspepsia—Epirubicin—stomach cancer	3.96e-05	0.00594	CcSEcCtD
Icosapent—Gastrointestinal disorder—Epirubicin—stomach cancer	3.89e-05	0.00582	CcSEcCtD
Icosapent—Constipation—Epirubicin—stomach cancer	3.85e-05	0.00577	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.8e-05	0.00569	CcSEcCtD
Icosapent—Dyspepsia—Doxorubicin—stomach cancer	3.67e-05	0.00549	CcSEcCtD
Icosapent—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.6e-05	0.00539	CcSEcCtD
Icosapent—Constipation—Doxorubicin—stomach cancer	3.56e-05	0.00534	CcSEcCtD
Icosapent—Pruritus—Methotrexate—stomach cancer	3.4e-05	0.0051	CcSEcCtD
Icosapent—Pruritus—Epirubicin—stomach cancer	3.19e-05	0.00477	CcSEcCtD
Icosapent—Vomiting—Methotrexate—stomach cancer	3.06e-05	0.00458	CcSEcCtD
Icosapent—Rash—Methotrexate—stomach cancer	3.03e-05	0.00455	CcSEcCtD
Icosapent—Dermatitis—Methotrexate—stomach cancer	3.03e-05	0.00454	CcSEcCtD
Icosapent—Pruritus—Doxorubicin—stomach cancer	2.95e-05	0.00442	CcSEcCtD
Icosapent—Vomiting—Epirubicin—stomach cancer	2.86e-05	0.00429	CcSEcCtD
Icosapent—Rash—Epirubicin—stomach cancer	2.84e-05	0.00425	CcSEcCtD
Icosapent—Dermatitis—Epirubicin—stomach cancer	2.84e-05	0.00425	CcSEcCtD
Icosapent—Vomiting—Doxorubicin—stomach cancer	2.65e-05	0.00397	CcSEcCtD
Icosapent—Rash—Doxorubicin—stomach cancer	2.63e-05	0.00394	CcSEcCtD
Icosapent—Dermatitis—Doxorubicin—stomach cancer	2.62e-05	0.00393	CcSEcCtD
Icosapent—PPARG—Gene Expression—DNMT1—stomach cancer	1.62e-05	0.000113	CbGpPWpGaD
Icosapent—PPARD—Metabolism—TYMS—stomach cancer	1.62e-05	0.000113	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	1.62e-05	0.000113	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	1.61e-05	0.000112	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—MAPK1—stomach cancer	1.61e-05	0.000112	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—EGFR—stomach cancer	1.61e-05	0.000112	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PTGS2—stomach cancer	1.6e-05	0.000112	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PTGS2—stomach cancer	1.6e-05	0.000112	CbGpPWpGaD
Icosapent—PPARD—Metabolism—GSTM1—stomach cancer	1.6e-05	0.000111	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.6e-05	0.000111	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—HSPA8—stomach cancer	1.6e-05	0.000111	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.59e-05	0.000111	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ALOX5—stomach cancer	1.58e-05	0.00011	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—MYC—stomach cancer	1.57e-05	0.000109	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—UMPS—stomach cancer	1.57e-05	0.000109	CbGpPWpGaD
Icosapent—PPARG—Metabolism—DPYD—stomach cancer	1.55e-05	0.000108	CbGpPWpGaD
Icosapent—PTGS2—Disease—WIF1—stomach cancer	1.55e-05	0.000108	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—PIK3CA—stomach cancer	1.54e-05	0.000107	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—SERPINE1—stomach cancer	1.54e-05	0.000107	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	1.53e-05	0.000107	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	1.53e-05	0.000107	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CA1—stomach cancer	1.53e-05	0.000106	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NDUFA2—stomach cancer	1.53e-05	0.000106	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CKB—stomach cancer	1.53e-05	0.000106	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—FBP1—stomach cancer	1.53e-05	0.000106	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—KRAS—stomach cancer	1.52e-05	0.000106	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6R—stomach cancer	1.51e-05	0.000105	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—TP53—stomach cancer	1.51e-05	0.000105	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—SERPINE1—stomach cancer	1.51e-05	0.000105	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	1.51e-05	0.000105	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ERCC2—stomach cancer	1.5e-05	0.000105	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—RPS6—stomach cancer	1.5e-05	0.000104	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	1.49e-05	0.000104	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—RHOA—stomach cancer	1.48e-05	0.000103	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—PPARG—stomach cancer	1.47e-05	0.000103	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NOS3—stomach cancer	1.47e-05	0.000102	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TNF—stomach cancer	1.46e-05	0.000102	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PDHA1—stomach cancer	1.46e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ECHS1—stomach cancer	1.46e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPL13—stomach cancer	1.46e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPL18—stomach cancer	1.46e-05	0.000101	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP2—stomach cancer	1.44e-05	0.000101	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PLIN2—stomach cancer	1.43e-05	9.99e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—MTHFR—stomach cancer	1.41e-05	9.84e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—PIK3CA—stomach cancer	1.4e-05	9.73e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CA2—stomach cancer	1.4e-05	9.72e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	1.39e-05	9.71e-05	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—IL6—stomach cancer	1.38e-05	9.64e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RNF43—stomach cancer	1.38e-05	9.61e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—ERBB2—stomach cancer	1.37e-05	9.55e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTT1—stomach cancer	1.37e-05	9.54e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TYMP—stomach cancer	1.37e-05	9.53e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—FADS1—stomach cancer	1.37e-05	9.53e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—RHOA—stomach cancer	1.37e-05	9.52e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NT5E—stomach cancer	1.36e-05	9.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PGAM1—stomach cancer	1.36e-05	9.47e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPS21—stomach cancer	1.36e-05	9.46e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPS15—stomach cancer	1.36e-05	9.46e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CYP2A6—stomach cancer	1.36e-05	9.43e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	1.33e-05	9.26e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—SERPINE1—stomach cancer	1.33e-05	9.25e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	1.33e-05	9.24e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—AKR1C3—stomach cancer	1.32e-05	9.18e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—CAV1—stomach cancer	1.3e-05	9.08e-05	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PIK3CA—stomach cancer	1.3e-05	9.07e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCL8—stomach cancer	1.3e-05	9.06e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—APOA1—stomach cancer	1.3e-05	9.06e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PLCE1—stomach cancer	1.3e-05	9.03e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALDH7A1—stomach cancer	1.3e-05	9.03e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—HRAS—stomach cancer	1.29e-05	9e-05	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TP53—stomach cancer	1.29e-05	8.97e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	1.29e-05	8.96e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ENO1—stomach cancer	1.28e-05	8.94e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—SREBF2—stomach cancer	1.28e-05	8.93e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CDKN1B—stomach cancer	1.27e-05	8.84e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—RORA—stomach cancer	1.27e-05	8.82e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—ERBB2—stomach cancer	1.27e-05	8.81e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.26e-05	8.8e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	1.26e-05	8.74e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—PPP2R1A—stomach cancer	1.25e-05	8.67e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.25e-05	8.67e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—UMPS—stomach cancer	1.24e-05	8.66e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL6—stomach cancer	1.24e-05	8.61e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCND1—stomach cancer	1.21e-05	8.44e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—JUN—stomach cancer	1.21e-05	8.42e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALDOB—stomach cancer	1.19e-05	8.27e-05	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL6—stomach cancer	1.18e-05	8.21e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MMP9—stomach cancer	1.18e-05	8.19e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CDKN1A—stomach cancer	1.17e-05	8.16e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	1.16e-05	8.07e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SMAD4—stomach cancer	1.16e-05	8.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PDHA1—stomach cancer	1.16e-05	8.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ECHS1—stomach cancer	1.16e-05	8.05e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PPARG—stomach cancer	1.15e-05	7.98e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MAPK8—stomach cancer	1.14e-05	7.97e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CD44—stomach cancer	1.14e-05	7.93e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ALDOB—stomach cancer	1.13e-05	7.84e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.12e-05	7.8e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.12e-05	7.78e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.11e-05	7.7e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALOX5—stomach cancer	1.1e-05	7.69e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPL15—stomach cancer	1.1e-05	7.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.1e-05	7.64e-05	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PIK3CA—stomach cancer	1.09e-05	7.6e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—FADS1—stomach cancer	1.09e-05	7.57e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TYMP—stomach cancer	1.09e-05	7.57e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—DPYD—stomach cancer	1.09e-05	7.56e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MMP9—stomach cancer	1.09e-05	7.56e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NPM1—stomach cancer	1.08e-05	7.54e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.07e-05	7.43e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—VEGFA—stomach cancer	1.06e-05	7.36e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—ERCC2—stomach cancer	1.06e-05	7.35e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RBP4—stomach cancer	1.05e-05	7.29e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—STAT3—stomach cancer	1.05e-05	7.28e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.04e-05	7.27e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.04e-05	7.27e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ALB—stomach cancer	1.03e-05	7.18e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPS26—stomach cancer	1.03e-05	7.17e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PPIA—stomach cancer	1.02e-05	7.11e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—SREBF2—stomach cancer	1.02e-05	7.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—RORA—stomach cancer	1.01e-05	7e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MAPK3—stomach cancer	1e-05	6.96e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	9.94e-06	6.92e-05	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PIK3CA—stomach cancer	9.87e-06	6.87e-05	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PIK3CA—stomach cancer	9.87e-06	6.87e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	9.86e-06	6.86e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—NOS3—stomach cancer	9.86e-06	6.86e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.84e-06	6.85e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—VEGFA—stomach cancer	9.75e-06	6.79e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MYC—stomach cancer	9.72e-06	6.77e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PPP2R1A—stomach cancer	9.69e-06	6.74e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—STAT3—stomach cancer	9.65e-06	6.72e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTT1—stomach cancer	9.6e-06	6.69e-05	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—MYC—stomach cancer	9.53e-06	6.64e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MAPK1—stomach cancer	9.51e-06	6.62e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—EGFR—stomach cancer	9.51e-06	6.62e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTP1—stomach cancer	9.5e-06	6.62e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CYP2A6—stomach cancer	9.49e-06	6.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALDOB—stomach cancer	9.43e-06	6.56e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—HMOX1—stomach cancer	9.37e-06	6.52e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—AKR1C3—stomach cancer	9.23e-06	6.43e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MAPK3—stomach cancer	9.22e-06	6.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	9.06e-06	6.31e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PTGS2—stomach cancer	9.02e-06	6.28e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ENO1—stomach cancer	9e-06	6.27e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—KRAS—stomach cancer	8.98e-06	6.25e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.89e-06	6.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.87e-06	6.17e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.85e-06	6.16e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—TYMS—stomach cancer	8.83e-06	6.15e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—MAPK1—stomach cancer	8.78e-06	6.11e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—EGFR—stomach cancer	8.77e-06	6.11e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALOX5—stomach cancer	8.76e-06	6.1e-05	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	8.76e-06	6.1e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—AKR1C3—stomach cancer	8.75e-06	6.09e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPS19—stomach cancer	8.75e-06	6.09e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GSTM1—stomach cancer	8.73e-06	6.08e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MAPK3—stomach cancer	8.64e-06	6.02e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—DPYD—stomach cancer	8.62e-06	6e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ENO1—stomach cancer	8.53e-06	5.94e-05	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—MYC—stomach cancer	8.4e-06	5.85e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TNF—stomach cancer	8.36e-06	5.82e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—KRAS—stomach cancer	8.29e-06	5.77e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—PIK3CA—stomach cancer	8.25e-06	5.75e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ERCC2—stomach cancer	8.21e-06	5.72e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TP53—stomach cancer	7.98e-06	5.56e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CD44—stomach cancer	7.98e-06	5.56e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.81e-06	5.44e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.74e-06	5.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RPS6—stomach cancer	7.74e-06	5.39e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—MTHFR—stomach cancer	7.72e-06	5.37e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—HRAS—stomach cancer	7.64e-06	5.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTT1—stomach cancer	7.62e-06	5.31e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD44—stomach cancer	7.57e-06	5.27e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CYP2A6—stomach cancer	7.54e-06	5.25e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—AKR1C3—stomach cancer	7.33e-06	5.1e-05	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL6—stomach cancer	7.31e-06	5.09e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—SERPINE1—stomach cancer	7.25e-06	5.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ENO1—stomach cancer	7.14e-06	4.97e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—CAV1—stomach cancer	7.12e-06	4.96e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HBEGF—stomach cancer	7.11e-06	4.95e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—APOA1—stomach cancer	7.1e-06	4.94e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—HRAS—stomach cancer	7.05e-06	4.91e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.03e-06	4.89e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.8e-06	4.73e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPP2R1A—stomach cancer	6.79e-06	4.72e-05	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6—stomach cancer	6.74e-06	4.69e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTP1—stomach cancer	6.66e-06	4.63e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—HMOX1—stomach cancer	6.57e-06	4.57e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PPP2R1A—stomach cancer	6.43e-06	4.48e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CD44—stomach cancer	6.34e-06	4.41e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—TYMS—stomach cancer	6.19e-06	4.31e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GSTM1—stomach cancer	6.12e-06	4.26e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SMAD4—stomach cancer	5.97e-06	4.16e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ERCC2—stomach cancer	5.75e-06	4e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FYN—stomach cancer	5.67e-06	3.95e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ALB—stomach cancer	5.63e-06	3.92e-05	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PIK3CA—stomach cancer	5.55e-06	3.86e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERCC2—stomach cancer	5.45e-06	3.8e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—MTHFR—stomach cancer	5.41e-06	3.76e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPP2R1A—stomach cancer	5.39e-06	3.75e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—NOS3—stomach cancer	5.38e-06	3.75e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—FGFR2—stomach cancer	5.32e-06	3.71e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTP1—stomach cancer	5.28e-06	3.68e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—HMOX1—stomach cancer	5.21e-06	3.63e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MTHFR—stomach cancer	5.12e-06	3.57e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—CAV1—stomach cancer	4.99e-06	3.47e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—APOA1—stomach cancer	4.98e-06	3.46e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PTGS2—stomach cancer	4.92e-06	3.43e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—TYMS—stomach cancer	4.91e-06	3.42e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IRS2—stomach cancer	4.88e-06	3.39e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GSTM1—stomach cancer	4.86e-06	3.38e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.76e-06	3.32e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CAV1—stomach cancer	4.73e-06	3.29e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MAPK3—stomach cancer	4.72e-06	3.28e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APOA1—stomach cancer	4.72e-06	3.28e-05	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—MYC—stomach cancer	4.59e-06	3.19e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ERCC2—stomach cancer	4.57e-06	3.18e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6ST—stomach cancer	4.48e-06	3.12e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPARG—stomach cancer	4.38e-06	3.05e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—APC—stomach cancer	4.31e-06	3e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—MTHFR—stomach cancer	4.29e-06	2.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6R—stomach cancer	4e-06	2.78e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—CAV1—stomach cancer	3.96e-06	2.76e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—APOA1—stomach cancer	3.95e-06	2.75e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ALB—stomach cancer	3.94e-06	2.74e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.78e-06	2.63e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—NOS3—stomach cancer	3.77e-06	2.63e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—SERPINE1—stomach cancer	3.74e-06	2.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—RHOA—stomach cancer	3.61e-06	2.51e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—NOS3—stomach cancer	3.57e-06	2.49e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPARG—stomach cancer	3.48e-06	2.42e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PTGS2—stomach cancer	3.45e-06	2.4e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—ERBB2—stomach cancer	3.34e-06	2.33e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ALB—stomach cancer	3.13e-06	2.18e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN1B—stomach cancer	3.1e-06	2.16e-05	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PIK3CA—stomach cancer	3.03e-06	2.11e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—NOS3—stomach cancer	2.99e-06	2.08e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—CDKN1A—stomach cancer	2.86e-06	1.99e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—STAT3—stomach cancer	2.55e-06	1.78e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MAPK3—stomach cancer	2.44e-06	1.7e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MYC—stomach cancer	2.37e-06	1.65e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—MAPK1—stomach cancer	2.32e-06	1.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—EGFR—stomach cancer	2.32e-06	1.61e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—KRAS—stomach cancer	2.19e-06	1.52e-05	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PIK3CA—stomach cancer	2.12e-06	1.48e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—PIK3CA—stomach cancer	2.01e-06	1.4e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—HRAS—stomach cancer	1.86e-06	1.3e-05	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6—stomach cancer	1.78e-06	1.24e-05	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PIK3CA—stomach cancer	1.68e-06	1.17e-05	CbGpPWpGaD
